Takeda and existing investor Allianz X took part in a series C round closed in the wake of heightened demand for Amwell's telehealth technology platform.

US-based telehealth technology provider Amwell completed a $194m series C round yesterday that was backed by pharmaceutical firm Takeda and Allianz X, insurance group Allianz’s digital investment arm. Formerly known as American Well, Amwell has built a telehealth system used by some 2,000 hospitals, allowing care providers to remotely speak to and assess patients. It…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.